Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16295164 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL4148731 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL646382 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL16293947 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL3768374 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL5403889 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL16295185 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL4148730 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL8158979 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 | |
| SCHEMBL8158977 | 1.00 | FAAH (0.48) | FAAHTRPV1MAPTTBXAS1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250019731-A1 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | AGAIN BIO APS (DK) | 2025-01-16 | — | — | US | disclosed |
| CN-118460487-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118374462-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-07-23 | — | — | CN | disclosed |
| US-11981952-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| CN-105378486-B | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20210071212-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | GENOMATICA, INC. (US) | 2021-03-11 | — | — | US | disclosed |
| EP-3745133-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | Genomatica, Inc. (US) | 2020-12-02 | — | — | EP | disclosed |
| US-10711288-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| EP-2984490-B1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | GENOMATICA INC (US) | 2020-05-20 | — | — | EP | disclosed |
| US-20160130616-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | AGAIN BIO APS (DK) | 2016-05-12 | — | — | US | disclosed |
| CN-105378486-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | ABBOTT LAB | 2016-03-02 | — | — | CN | disclosed |
| EP-2984490-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | REG Life Sciences, LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2014201474-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | LS9, INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| US-20100035311-A1 | METHOD AND COMPOSITION FOR ENZYME STORAGE | JOHN INNES CENTRE (GB) | 2010-02-11 | — | — | US | disclosed |
| EP-2084271-A1 | METHOD AND COMPOSITION FOR ENZYME STORAGE | Plant Bioscience Limited (GB) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008047112-A1 | METHOD AND COMPOSITION FOR ENZYME STORAGE | PLANT BIOSCIENCE LIMITED (GB) | 2008-04-24 | — | — | WO | disclosed |
| US-20060026712-A1 | Method for the generation of green-note compounds | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | FAAH 80/4885TRPV1 4260/4885MAPT 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.